AAV-CR1 mab (V3I-1Q1Q-HC1Q) Cas9-GFP-ASGR1 for B Cell Engineering (CAT#: BGS-0524-CR302)

The product is a highly efficient, inducible Cas9-GFP-ASGR1 gene-editing based novel AAV packaging system that can be used to mediate researches involving anti-CR1 mab (V3I-1Q1Q-HC1Q) in Horse B cell engineering.

Datasheet

Specifications

Clone V3I-1Q1Q-HC1Q
Host Human
Packaging Cell Line HEK 293
Vector Promoter CMV
Rep Rep68
Capsid VP3
Envelope Env
Matrix C-terminal
Size ~30kb
Genome dsDNA
Virus Type AAV
Cofactor Requirement No dNTPs
Particles/mL 6 × 10¹¹
PFU/mL 8.5 × 10¹¹
TU/mL 1.9 × 10¹¹
Cas9 Cas9-GFP
sgRNA ASGR1
Engineered B Cell Horse B cells

Target Information

Target CR1
Alternative Names CR1

Product Properties

Format Liquid
Shipping The product is shipped by dry ice.
Storage Upon receipt, store immediately at -80°C or lower for long-term storage. Avoid freeze/thaw cycles.
COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number
! For Research Use Only | Not For Clinical Use

Related products